Hikma Pharmaceuticals (LSE:HIK)
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.
About
Last updated 14-10-2019, 04:22:58pm BSTRelated Articles
-
This FTSE 250 stock has just raised full-year expectations. Time to buy?
The market loves a company that's beating previous estimates, and this FTSE 250 (INDEXFTSE: MCX) share is moving higher today. Read More »
-
An overlooked ex-FTSE 100 dividend stock I’d buy and hold forever
Roland Head explains why he'd buy this former FTSE 100 (INDEXFTSE: UKX) stock, despite its recent demotion to the FTSE 250. Read More »
-
Top shares for June 2019
We asked our freelance writers to share their top stock picks for the month. Read More »
-
Why I’d snap up this FTSE 100 pharmaceutical provider alongside GlaxoSmithKline
I like GlaxoSmithKline plc (LON: GSK), but I also think today’s update from this smaller FTSE 100 (INDEXFTSE: UKX) competitor is encouraging. Read More »
-
3 FTSE 100 shares I’d snap up for my Stocks and Shares ISA
The FTSE 100 index (INDEXFTSE: UKX) is packed with great shares and here are three that I like. Read More »
-
2 dividend stocks I’d buy for an ISA today
These dividend stocks could be big winners over the next decade, says Roland Head. Read More »
-
Could this FTSE 100 stock double your money again?
G A Chester discusses the outlook for this FTSE 100 (INDEXFTSE:UKX) big winner and a smaller-cap peer. Read More »
-
Forget Bitcoin! I think buying these 2 pharma stocks could be a better way to get rich
The healthcare segment may offer a stronger growth outlook than the virtual currency due to demographic change. Read More »
-
I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer
Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year. Read More »
-
Can this year’s biggest FTSE 250 winners keep it going in 2019?
2018 has been a great year for the top FTSE 250 (INDEXFTSE: MCX) stocks. Will 2019 see their strong run continuing? Read More »